KPMG 2024 Healthcare and Life Sciences Investment Outlook

This in-depth examination of the healthcare and life sciences (HCLS) deal market explores how the major developments of 2023 have prepared the way for the year ahead. In this paper, KPMG analyzes how eight subsectors fared during another year of industry challenges and global instability, and how deal activity and market drivers could shape the 2024 investment landscape. The insights of this report are based on extensive global research into the deal and market environments, as well as KPMG’s annual survey of corporate and private equity (PE) deal makers across the subsectors.

Read the full article: KPMG 2024 Healthcare and Life Sciences Investment Outlook //

Source: https://kpmg.com/kpmg-us/content/dam/kpmg/pdf/2024/HCLS-Investment-Outlook-010524.pdf

Leave a Comment

Your email address will not be published.

Scroll to Top